S

Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
HKEX:6990

Watchlist Manager
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
HKEX:6990
Watchlist
Price: 343.8 HKD 3.31% Market Closed
Market Cap: 78.1B HKD

Intrinsic Value

The intrinsic value of one Sichuan Kelun-Biotech Biopharmaceutical Co Ltd stock under the Base Case scenario is 160.09 HKD. Compared to the current market price of 343.8 HKD, Sichuan Kelun-Biotech Biopharmaceutical Co Ltd is Overvalued by 53%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
160.09 HKD
Overvaluation 53%
Intrinsic Value
Price
S
Worst Case
Base Case
Best Case

Valuation History
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for Sichuan Kelun-Biotech Biopharmaceutical Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

No research report yet

Want a deep‑dive on Sichuan Kelun-Biotech Biopharmaceutical Co Ltd?
Request it below and we’ll move it up the queue.

Request This Report
What’s Inside the Report:
Whether it’s a smart buy right now
If the stock is undervalued
Its long-term growth potential
Whether the dividend is safe
How it compares to peers
How strong its moat is
Whether management can be trusted
You Can Read These Reports Right Now
Dive in while we’re working on Sichuan Kelun-Biotech Biopharmaceutical Co Ltd’s research
View All Researches
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
HKEX:6990
CN
Biotechnology
Market Cap
78.1B HKD
IPO
Jul 11, 2023
CN
Biotechnology
Market Cap
78.1B HKD
IPO
Jul 11, 2023
Price
HK$false
EPS
ÂĄfalse
AI Assistant
AI Assistant
Ask me anything about Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
Financials
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd

Balance Sheet Decomposition
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd

Current Assets 3.5B
Cash & Short-Term Investments 3.1B
Receivables 306.6m
Other Current Assets 117.4m
Non-Current Assets 775.2m
PP&E 758.1m
Intangibles 2.6m
Other Non-Current Assets 14.5m
Efficiency

Free Cash Flow Analysis
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd

Revenue
1.9B CNY
Cost of Revenue
-659.4m CNY
Gross Profit
1.3B CNY
Operating Expenses
-1.4B CNY
Operating Income
-160.2m CNY
Other Expenses
-106.6m CNY
Net Income
-266.8m CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

Sichuan Kelun-Biotech Biopharmaceutical Co Ltd's profitability score is 33/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional Revenue Growth Forecast
Exceptional 1-Year Revenue Growth
Negative Free Cash Flow
33/100
Profitability
Score

Sichuan Kelun-Biotech Biopharmaceutical Co Ltd's profitability score is 33/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Sichuan Kelun-Biotech Biopharmaceutical Co Ltd's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
75/100
Solvency
Score

Sichuan Kelun-Biotech Biopharmaceutical Co Ltd's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd

Wall Street analysts forecast Sichuan Kelun-Biotech Biopharmaceutical Co Ltd stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Sichuan Kelun-Biotech Biopharmaceutical Co Ltd is 299.54 HKD with a low forecast of 204.69 HKD and a high forecast of 371.7 HKD.

Lowest
Price Target
204.69 HKD
40% Downside
Average
Price Target
299.54 HKD
13% Downside
Highest
Price Target
371.7 HKD
8% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for Sichuan Kelun-Biotech Biopharmaceutical Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one Sichuan Kelun-Biotech Biopharmaceutical Co Ltd stock?

The intrinsic value of one Sichuan Kelun-Biotech Biopharmaceutical Co Ltd stock under the Base Case scenario is 160.09 HKD.

Is Sichuan Kelun-Biotech Biopharmaceutical Co Ltd stock undervalued or overvalued?

Compared to the current market price of 343.8 HKD, Sichuan Kelun-Biotech Biopharmaceutical Co Ltd is Overvalued by 53%.

Back to Top